Prolonged release melatonin for improving sleep in totally blind subjects: a pilot placebo-controlled multicenter trial

scientific article

Prolonged release melatonin for improving sleep in totally blind subjects: a pilot placebo-controlled multicenter trial is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.2147/NSS.S71838
P8608Fatcat IDrelease_eeresitbpvgvhddisci7jmus44
P3181OpenCitations bibliographic resource ID4299800
P932PMC publication ID4319556
P698PubMed publication ID25678831

P2093author name stringThomas Roth
Nava Zisapel
Tali Nir
P2860cites workNightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safetyQ21245261
Prolonged-release formulation of melatonin (Circadin) for the treatment of insomniaQ22306021
Beta 1-adrenergic antagonists and melatonin reset the clock and restore sleep in a circadian disorder, Smith-Magenis syndromeQ22306504
How to trick mother nature into letting you fly around or stay up all nightQ23923291
Short-wavelength light sensitivity of circadian, pupillary, and visual awareness in humans lacking an outer retinaQ24684932
Stability, precision, and near-24-hour period of the human circadian pacemakerQ28138096
Suppression of melatonin secretion in some blind patients by exposure to bright lightQ28242632
Human phase response curves to three days of daily melatonin: 0.5 mg versus 3.0 mgQ28382973
Nocturnal melatonin onset is phase locked to the primary sleep gate.Q53967255
Light suppresses melatonin secretion in humansQ54294567
Relationship between Napping and Melatonin in the BlindQ61055166
The human phase response curve (PRC) to melatonin is about 12 hours out of phase with the PRC to lightQ74287351
Is there an intrinsic period of the circadian clock?Q95787724
The dim light melatonin onset, melatonin assays and biological rhythm research in humansQ33543309
Melatonin in circadian sleep disorders in the blind.Q33543314
Entrainment of free-running circadian rhythms by melatonin in blind peopleQ33921061
Larger phase angle between sleep propensity and melatonin rhythms in sighted humans with non-24-hour sleep-wake syndrome.Q34113213
Different types of melatonin circadian secretory rhythms in some blind subjectsQ34271484
The effects of low-dose 0.5-mg melatonin on the free-running circadian rhythms of blind subjects.Q34272772
Circadian rhythm sleep disorders: pathophysiology and potential approaches to managementQ34313513
Melatonin stabilises sleep onset time in a blind man without entrainment of cortisol or temperature rhythmsQ34351384
Melatonin as a chronobiotic.Q34384226
How to read a paper. Statistics for the non-statistician. II: "Significant" relations and their pitfallsQ34437356
Circadian rhythm sleep disorders: lessons from the blindQ35046580
Melatonin role in experimental arthritisQ35698714
Tasimelteon: first global approvalQ38194529
Statistical and clinical significance, and how to use confidence intervals to help interpret bothQ39888306
Circadian rhythms: basic neurobiology and clinical applicationsQ41360588
Melatonin treatment for eastward and westward travel preparationQ43219782
Sleep/wake cycles in the dark: sleep recorded by polysomnography in 26 totally blind subjects compared to controlsQ44154819
Photic resetting of the human circadian pacemaker in the absence of conscious visionQ44238206
Melatonin phase-shifts human circadian rhythms with no evidence of changes in the duration of endogenous melatonin secretion or the 24-hour production of reproductive hormonesQ44582508
Melatonin acutely improves the neuroendocrine architecture of sleep in blind individualsQ44645551
Eventual entrainment of the human circadian pacemaker by melatonin is independent of the circadian phase of treatment initiation: clinical implicationsQ44765058
Timing light treatment for eastward and westward travel preparationQ44883866
Melatonin and zopiclone as facilitators of early circadian sleep in operational air transport crews.Q44902784
Melatonin advances the circadian timing of EEG sleep and directly facilitates sleep without altering its duration in extended sleep opportunities in humansQ45086588
Sleep-facilitating effect of exogenous melatonin in healthy young men and women is circadian-phase dependentQ48497328
The circadian body temperature rhythm in the elderly: effect of single daily melatonin dosingQ48498315
Sleep and activity rhythms are related to circadian phase in the blind.Q48748816
Disturbance of sleep in blindnessQ48783990
Association of sleep-wake habits in older people with changes in output of circadian pacemakerQ48882717
Melatonin rhythms in night shift workersQ48883129
Melatonin Administration to Blind People: Phase Advances and EntrainmentQ48914251
P275copyright licenseCreative Commons Attribution-NonCommercial 3.0 UnportedQ18810331
P6216copyright statuscopyrightedQ50423863
P407language of work or nameEnglishQ1860
P921main subjectmelatoninQ180912
placeboQ269829
multicenter clinical trialQ6934595
sleepQ35831
P304page(s)13-23
P577publication date2015-01-01
P1433published inNature and Science of SleepQ15817879
P1476titleProlonged release melatonin for improving sleep in totally blind subjects: a pilot placebo-controlled multicenter trial
P478volume7

Reverse relations

cites work (P2860)
Q28074572Comparative Review of Approved Melatonin Agonists for the Treatment of Circadian Rhythm Sleep-Wake Disorders
Q60304311Long-Term Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children with Autism Spectrum Disorder
Q28083929MT1 and MT2 Melatonin Receptors: A Therapeutic Perspective
Q92404206Melatonin: Countering Chaotic Time Cues
Q47557441New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation
Q47349614Non-24-Hour Sleep–Wake Rhythm Disorder in the Totally Blind: Diagnosis and Management.
Q64119035Prolonged-release melatonin in patients with idiopathic REM sleep behavior disorder
Q91784560Sleep-Wake Disturbance Related to Ocular Disease: A Systematic Review of Phase-Shifting Pharmaceutical Therapies
Q52641607Synthetic pathways and processes for effective production of 5-hydroxytryptophan and serotonin from glucose in Escherichia coli.
Q37151830The Efficacy of Oral Melatonin in Improving Sleep in Cancer Patients with Insomnia: A Randomized Double-Blind Placebo-Controlled Study
Q90257027The Risk of Night Shift Workers to the Glucose Blood Levels, Saliva, and Dental Caries

Search more.